Information:
Fel:
ID
32255
Beskrivning
Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01300364
Länk
https://clinicaltrials.gov/show/NCT01300364
Nyckelord
Versioner (1)
- 2018-10-24 2018-10-24 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
24 oktober 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Schizophrenia NCT01300364
Eligibility Schizophrenia NCT01300364
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT01300364
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Schizophrenia
Item
diagnosis of schizophrenia (dsm-iv criteria)
boolean
C0036341 (UMLS CUI [1])
Antipsychotic Agents Dose Stable | olanzapine | Risperidone
Item
stable doses of antipsychotic medication (olanzapine, risperidone)for at least 60 days prior to study initiation
boolean
C0040615 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0171023 (UMLS CUI [2])
C0073393 (UMLS CUI [3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0171023 (UMLS CUI [2])
C0073393 (UMLS CUI [3])
Symptoms Negative | PANSS Symptoms Negative
Item
presence of significant negative symptoms (defined as one or more negative symptom score grater than 4 in the panss scale) (kay 1987)
boolean
C1457887 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
C4086747 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
C1513916 (UMLS CUI [1,2])
C4086747 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
Informed Consent
Item
patients have to give written informed consent to participate in the study
boolean
C0021430 (UMLS CUI [1])
Substance Use Disorders | Substance Dependence
Item
patients with a substance abuse/dependence diagnosis in the previous six months.
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
C0038580 (UMLS CUI [2])
Mental Retardation
Item
mental retardation.
boolean
C0025362 (UMLS CUI [1])
Antidepressive Agents
Item
patients taking antidepressant in the last 4 months before the trial.
boolean
C0003289 (UMLS CUI [1])
Antipsychotic Agents Other | Exception Sinequan | Exception Entumine | Exception Largactil | Exception Seroquel
Item
patients taking other antipsychotic medication, except: sinquan 100, entumine 40, largactil 100 and seroquel 200.
boolean
C0040615 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0728757 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0950873 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0600062 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0287163 (UMLS CUI [5,2])
C0205394 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0728757 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0950873 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0600062 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0287163 (UMLS CUI [5,2])
Hamilton rating scale for depression
Item
patients who score more than 20 in hamilton rating scale for depression.
boolean
C0451203 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Renal Insufficiency Serious
Item
serious impaired kidney function.
boolean
C1565489 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Hemorrhagic Disorders
Item
history of hemorrhagic disorders.
boolean
C0019087 (UMLS CUI [1])
Hypersensitivity reboxetine | Citalopram allergy
Item
reboxetine or citalopram allergy.
boolean
C0020517 (UMLS CUI [1,1])
C0168388 (UMLS CUI [1,2])
C0570769 (UMLS CUI [2])
C0168388 (UMLS CUI [1,2])
C0570769 (UMLS CUI [2])